Skip to content 
Harvard Dana-Farber Cancer Institute’s ASH Highlights 2025 This activity is designed to educate hematologists, oncologists, and other clinicians on new developments in the diagnosis and treatment of all blood cancers. Through disease specific lectures, highlighting the most clinically relevant data presented at the ASH Annual Meeting, attendees will be able to identify and describe the emerging treatments available and to utilize these treatments available in their professional practice.
The American Society of Hematology’s annual meeting in December is the venue at which cutting edge therapeutic advances are presented publicly for the first time. Unfortunately, only a small fraction of practitioners can attend this meeting. It is therefore of vital importance for practitioners and, in turn, their patients to have access to emerging data in a timely fashion. At this one-day activity, attendees will receive relevant updates on advances in acute leukemia, myelodysplasia, myeloproliferative disorders, chronic myelogenous leukemia, chronic lymphocytic leukemia, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, multiple myeloma, Waldenstrom’s macroglobulinemia, coagulation disorders, hematopoietic stem cell transplantation, and CAR-T therapies.
Who Should Attend
This course is targeted to Oncology and Hematology Physicians and Trainees, Primary Care Physicians, Nurses, Physician Assistants, and Nurse Practitioners.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Describe an overview and highlight the recent medical advances present at the Annual Meeting of the American Society of Hematologists (ASH) which will help physicians achieve better patient outcomes.
- Recognize appropriate management and treatment options for hematologic malignancies.
- Utilize these approaches in routine clinical practice.
- Review new therapies and approaches in non-malignant hematology.
Saturday, February 8, 2025
Welcome and Introduction
Ann S. LaCasce, MD
ASH 2024: Transplant Highlights
Mahasweta Gooptu, MD
ASH 2024: ALL, CML and MPNs Highlights
Daniel DeAngelo, MD, PhD
ASH 2024: Classical Hematology Highlights
Nathan T. Connell, MD, MPH
ASH 2024: MDS and AML
Richard M. Stone, MD
15-minute Break
ASH 2024: CLL Highlights
Inhye E. Ahn, MD
ASH 2024: Multiple Myeloma Highlights
Shonali Midha, MD
ASH 2024: Lymphoma Highlights
Jennifer L. Crombie, MD
ASH 2024: CAR-T Highlights
Caron A. Jacobson, MD
Closing Remarks
Ann S. LaCasce, MD
Dr. Sarah Thompson, Hematology –
This course provided an excellent overview of the latest advancements in hematology. Each session was packed with valuable insights!
Dr. Michael Chen, Oncology –
“The faculty were outstanding! Their expertise and ability to convey complex topics made the learning experience enjoyable.”
Dr. Emily Patel, Blood Disorders: –
“The structure of the course was logical and easy to follow, making it simple to grasp the key takeaways from each presentation.”
Dr. James Lee, Pediatric Hematology –
“Having the course recorded and available on Google Drive was a game-changer. I could revisit sessions at my convenience.”
Dr. Laura Kim, Clinical Research –
“I appreciated the focus on cutting-edge research and clinical applications. It’s crucial for staying updated in the field.”
Dr. Natalie Clark, Research Scientist –
“I would highly recommend this course to anyone in the oncology field. It’s a fantastic resource for professional development.”
Dr. Matthew Brown, Bone Marrow Transplant –
“I felt motivated after completing this course. The passion of the speakers was contagious!”
Dr. Julia Patel, Molecular Hematology –
“This course will serve as a great reference for my practice. The materials provided were comprehensive and well-curated.”
Dr. Angela Rivera, Blood Cancer Specialist –
“The discussions in the course allowed for networking with other professionals, which is invaluable in our field.”
Dr. David Wong, Adult Hematology –
“I found the practical applications of the research particularly helpful. It’s great to see theory translated into practice.”
Dr. Rachel Adams, Transfusion Medicine –
“The presenters did a fantastic job of breaking down complex information into digestible parts. I left feeling informed and inspired!”